The Food and Drug Administration is facing some backlash from hedge fund manager Bill Ackman about how long it took to ban Red No. 3 from the U.S. supply chain.
Bill Ackman, the owner of investment firm Pershing Square, said on Saturday that he is reincorporating his management company ...